Company / Assets per Share
ENANTA PHARMACEUTICALS INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$13.25
FY2025
5-year range
$13.25 / $22.23
FY2021-FY2025
Trend
-25.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $13.25 in FY2025 to $25.26 in FY2019.
Based on SEC 10-K filings.
13.25 in FY2025 with a 5-year CAGR of -11.7%.
Declined from $22.23 to $13.25 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.6%
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 25.9% year-over-year.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.25 | -25.9% |
| FY2024 | $17.89 | -19.6% |
| FY2023 | $22.23 | +19.9% |
| FY2022 | $18.55 | -15.1% |
| FY2021 | $21.86 | -11.4% |
| FY2020 | $24.67 | -2.3% |
| FY2019 | $25.26 | +16.6% |
| FY2018 | $21.66 | +26.3% |
| FY2017 | $17.16 | +14.2% |
| FY2016 | $15.03 | +13.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026